6/6
11:09 am
drma
Moderate to Severe Acne Pipeline Landscape Analysis, 2024, Featuring Emerging Therapies ASC40 (Ascletis Pharma), BTX 1503 (Botanix Pharmaceuticals), and More [Yahoo! Finance]
Medium
Report
Moderate to Severe Acne Pipeline Landscape Analysis, 2024, Featuring Emerging Therapies ASC40 (Ascletis Pharma), BTX 1503 (Botanix Pharmaceuticals), and More [Yahoo! Finance]
5/27
05:33 am
drma
Acne Vulgaris Market to Register Sustainable Growth by 2034, Examines DelveInsight | Key Companies - Dermata Therapeutics, AstraZeneca, Novartis Pharmaceuticals, UCB Pharma, Incyte Corporation [Yahoo! Finance]
Medium
Report
Acne Vulgaris Market to Register Sustainable Growth by 2034, Examines DelveInsight | Key Companies - Dermata Therapeutics, AstraZeneca, Novartis Pharmaceuticals, UCB Pharma, Incyte Corporation [Yahoo! Finance]
5/17
08:48 am
drma
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
Medium
Report
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
5/17
08:30 am
drma
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
High
Report
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
3/27
04:09 pm
drma
Dermata to Present at the Emerging Growth Conference on April 3, 2024 [Yahoo! Finance]
Low
Report
Dermata to Present at the Emerging Growth Conference on April 3, 2024 [Yahoo! Finance]
3/27
04:05 pm
drma
Dermata to Present at the Emerging Growth Conference on April 3, 2024
Low
Report
Dermata to Present at the Emerging Growth Conference on April 3, 2024
3/21
04:14 pm
drma
Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results [Yahoo! Finance]
6/7
05:12 pm
drma
Form 8-K Dermata Therapeutics, For: Jun 07
Medium
Report
Form 8-K Dermata Therapeutics, For: Jun 07
6/7
05:10 pm
drma
Form 424B5 Dermata Therapeutics,
Medium
Report
Form 424B5 Dermata Therapeutics,
6/5
09:03 am
drma
Form 8-K Dermata Therapeutics, For: Jun 04
Low
Report
Form 8-K Dermata Therapeutics, For: Jun 04
5/24
04:06 pm
drma
Form 8-K Dermata Therapeutics, For: May 20
Medium
Report
Form 8-K Dermata Therapeutics, For: May 20
5/17
04:09 pm
drma
Form 8-K Dermata Therapeutics, For: May 17
High
Report
Form 8-K Dermata Therapeutics, For: May 17
5/15
09:02 am
drma
Form 8-K Dermata Therapeutics, For: May 14
Low
Report
Form 8-K Dermata Therapeutics, For: May 14
5/14
09:16 am
drma
Form 8-K Dermata Therapeutics, For: May 14
Medium
Report
Form 8-K Dermata Therapeutics, For: May 14
5/7
05:11 pm
drma
Form 8-K Dermata Therapeutics, For: May 07
Low
Report
Form 8-K Dermata Therapeutics, For: May 07
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register